CR7060A - PREGABALINE-LACTOSE CONJUGATES - Google Patents
PREGABALINE-LACTOSE CONJUGATESInfo
- Publication number
- CR7060A CR7060A CR7060A CR7060A CR7060A CR 7060 A CR7060 A CR 7060A CR 7060 A CR7060 A CR 7060A CR 7060 A CR7060 A CR 7060A CR 7060 A CR7060 A CR 7060A
- Authority
- CR
- Costa Rica
- Prior art keywords
- lactose
- disorders
- pregabaline
- pregabalin
- disorder
- Prior art date
Links
- 239000008101 lactose Substances 0.000 title abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 208000035475 disorder Diseases 0.000 abstract 2
- 208000019901 Anxiety disease Diseases 0.000 abstract 1
- 206010010904 Convulsion Diseases 0.000 abstract 1
- 208000023105 Huntington disease Diseases 0.000 abstract 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 abstract 1
- 208000012902 Nervous system disease Diseases 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 abstract 1
- 208000018737 Parkinson disease Diseases 0.000 abstract 1
- 208000028017 Psychotic disease Diseases 0.000 abstract 1
- 206010043118 Tardive Dyskinesia Diseases 0.000 abstract 1
- 230000036506 anxiety Effects 0.000 abstract 1
- 208000015114 central nervous system disease Diseases 0.000 abstract 1
- 206010015037 epilepsy Diseases 0.000 abstract 1
- AYXYPKUFHZROOJ-ZETCQYMHSA-N pregabalin Chemical compound CC(C)C[C@H](CN)CC(O)=O AYXYPKUFHZROOJ-ZETCQYMHSA-N 0.000 abstract 1
- 229960001233 pregabalin Drugs 0.000 abstract 1
- 208000019116 sleep disease Diseases 0.000 abstract 1
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Se proporcionan compuestos conjugados de pregabalina-lactosa, tambien se proporciona como parte de la presente invencion un nuevo metodo para tratar en un sujeto trastornos o enfermedades del sistema nervioso central, que incluyen trastornos o crisis convulsivas, dolor, depresion, ansiedad, trastornos del sueno, trastornos consuntivos, psicosis, discinesia tardia, enfermedades de Huntington o Parkinson, administrando al sujeto una cantidad farmaceuticamente eficaz de un conjugado de pregabalina lactosa.Conjugated pregabalin-lactose compounds are provided, a new method for treating a central nervous system disorder or disorder, including seizure disorders or seizures, pain, depression, anxiety, sleep disorders, is also provided as part of the present invention. , consumptive disorders, psychosis, tardive dyskinesia, Huntington's or Parkinson's diseases, administering to the subject a pharmaceutically effective amount of a pregabalin lactose conjugate.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CR7060A CR7060A (en) | 2003-08-26 | 2003-08-26 | PREGABALINE-LACTOSE CONJUGATES |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CR7060A CR7060A (en) | 2003-08-26 | 2003-08-26 | PREGABALINE-LACTOSE CONJUGATES |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CR7060A true CR7060A (en) | 2004-02-23 |
Family
ID=44839116
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CR7060A CR7060A (en) | 2003-08-26 | 2003-08-26 | PREGABALINE-LACTOSE CONJUGATES |
Country Status (1)
| Country | Link |
|---|---|
| CR (1) | CR7060A (en) |
-
2003
- 2003-08-26 CR CR7060A patent/CR7060A/en not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DOP2002000356A (en) | CONJUGADOS DE PREGABALINA LACTOSA | |
| DK1259243T3 (en) | Bupropion metabolites, processes for their preparation and their use | |
| ES2156162T3 (en) | ACTIVE COMPOUNDS IN A NEW SITE ON CALCIUM CHANNELS OPERATED BY A RECEIVER, USEFUL FOR THE TREATMENT OF DISORDERS AND NEUROLOGICAL DISEASES. | |
| BRPI0408026A (en) | Quinazolines useful as ion channel modulators | |
| WO2002042462A3 (en) | Therapeutic agents and methods of use thereof for treating an amyloidogenic disease | |
| BRPI0811956A8 (en) | TOPICAL NON-AQUEOUS DICLOFENAC SOLUTION AND PROCESS FOR ITS PREPARATION | |
| MX2010004614A (en) | Compositions for treating parkinson's disease. | |
| MX2010009767A (en) | Use of mesenchymal stem cells for treating genetic diseases and disorders. | |
| BR0108977A (en) | Azacyclic compounds for use in the treatment of serotonin-related diseases | |
| ES2144623T3 (en) | DAILY BICYCLE HETERO CYCLES AS CYCLOOXYGENASE-2 INHIBITORS. | |
| BE2012C040I2 (en) | ||
| CU23167A3 (en) | INHIBITORS OF THE RECOVERY OF MONOAMINS FOR THE TREATMENT OF CNS DISORDERS | |
| BRPI0510094A (en) | use of flibanserin for premenstrual treatment and other female sexual disorders | |
| GT200500086A (en) | ESTEREOSELECTIVE BIOCONVERSION OF ALIFATIC DINITRILS IN CYANOCARBOXYL ACIDS. | |
| EA200300854A1 (en) | APPLICATION OF REVERSE AGONISTS OF THE GUMKA IN COMBINATION WITH PARTIAL AGONISTS OF NICOTINE RECEPTORS, ESTROGEN, ELECTORAL MODULATORS OF ESTROGEN OR VITAMIN E FOR TREATMENT OF COGNITIVE RADIATION. | |
| MX337396B (en) | Method of treating polycystic kidney diseases with ceramide derivatives. | |
| WO2004017904A3 (en) | Corticosteroid conjugates and uses thereof | |
| IL188172A0 (en) | Acyloxyalkyl carbamate prodrugs of tranexamic acid, methods of synthesis and use | |
| PL1976544T3 (en) | Method of using guava extract and composition including guava extract | |
| BRPI0410651A (en) | compound, pharmaceutical composition, and methods for treating or preventing cancer, wet-type macular degeneration or rheumatoid arthritis, aberrant vascularization, excess copper levels, obesity, and neurodegenerative disease in a patient | |
| TW200640467A (en) | Compounds and uses thereof | |
| BRPI0513395A (en) | use of a steroid to increase skin permeability | |
| WO2002015841A3 (en) | Medicine for treating female sexual dysfunction by acting on the central nervous system | |
| BRPI0412000A (en) | epothilone cancer treatment | |
| EP1764134A3 (en) | Tetrahydroindolone and purine derivatives linked to arylpiperazines |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal (granting procedure) |